More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+750.0% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 88.56 +0.85 (0.97%)
Prev. Close $87.71  
Open$88.10 
52 Wk High$ 
52 Wk Low$ 
Day High$89.29 
Day Low$87.73 
P/E N/A  
EPS$ 
Volume455,706 

Friends, Peers and Foes (?): 0A3M, MRNA, PFE, NVAX, CVAC (more...)

Oct 19, 2026 07:26 AM Form 6-K BioNTech SE For: Oct 19
Oct 19, 2026 06:45 AM BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
Oct 18, 2026 08:00 PM U.S. biotech SMids: Q3 earnings preview
Oct 14, 2026 06:35 AM BioNTech (BNTX) PT Lowered to $132 at Canaccord
Oct 13, 2026 04:09 PM Form 6-K BioNTech SE For: Oct 13
Oct 13, 2026 07:59 AM BioNTech stock falls after cancer trial misses key endpoint
Oct 13, 2026 06:45 AM BioNTech cancer trial misses progression-free survival endpoint
Oct 13, 2026 06:45 AM BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer 
Oct 9, 2026 04:47 PM Form 4 BioNTech SE For: Oct 08 Filed by: Sahin Ugur
Oct 8, 2026 08:40 AM Argus Starts BioNTech (BNTX) at Hold
View All Articles

Entities mentioned with BNTX

View All Entities